- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Jim Cramer likes Xilinx and Abbott Labs, but he's bearish on Xerox and Huntsman.
Comey's testimony? U.K. elections? Eurozone news? These can be new buying opportunities, says Jim Cramer.
The Huntsman-Clariant deal has the makings of an inversion -- and it may be a sign of hopes the Trump administration will ease regulations on such cross-border deals.
Donald Trump gives Wall Street a burst of relief on Monday after causing worry on markets for the previous two weeks.